Pfizer returning ED device to pharmacies

(Drug Topics) The Caverject Impulse Dual Chamber System, a drug delivery device used to treat erectile dysfunction that was withdrawn by the manufacturer, will return to pharmacy shelves, according to Pfizer, Inc. Pfizer could not say when it will resume production of the device, which it said it withdrew “several months ago.” Read more

Pancreatic Drug Trial Halted on Promising Results (HealthDay)

(HealthDay) Drug maker Pfizer Inc. said Thursday that a late-stage clinical trial of its cancer drug Sutent has been stopped early, because it showed significant benefit for patients with a rare form of pancreatic cancer. Read more

Pfizer Grabs Rights to Sell More Generics

(Wall Street Journal) Pfizer is diving deeper into generic drugs.

The company said today it has inked a set of deals with Indian generics maker Aurobindo Pharma for rights to 39 generic oral drugs in the U.S. and 31 in Europe, including 11 in France alone. The drugs are for heart disease and neurological disorders, among other things. The company will sell the drugs in the U.S. through its Greenstone generics unit. Read more